College of Engineering, Design & Computing Events

Letter of Intent due 26 June | ML/AI Tools to Advance Genomic Translational Research (MAGen) - Development Sites (UG3/UH3 Clinical Trials Not Allowed)Letter of Intent due

| All Day
Contact :
Alison Pearks
Email :
alison.pearks@ucdenver.edu

Letter of Intent due 26 June | ML/AI Tools to Advance Genomic Translational Research (MAGen) - Development Sites (UG3/UH3 Clinical Trials Not Allowed)

Letter of Intent due 26 June | ML/AI Tools to Advance Genomic Translational Research (MAGen) – Coordinating Center (UG3/UH3 Clinical Trials Not Allowed)

NIH

NHGRI aims to establish a research Consortium, ML/AI Tools to Advance Genomic Translational Research (MAGen), to collaboratively identify both genomic and non-genomic factors influencing disease development in individuals carrying pathogenic genetic variants. The ML/AI tools will leverage existing multimodal genomic and non-genomic data and will be cross validated in genomic translational research settings to ensure the robustness and generalizability of the tools for translational purposes.

 

CMS Login